ZNF619 and epilepsy: In our epilepsy cohort, stratifying patients by median IPI age revealed that LSR, PARP1, and ZNF619 are significantly upregulated in those with later-onset or more severe presentations, suggesting that m6A regulation of lipid metabolism, DNA repair/stress response, and synaptic plasticity may modulate disease trajectory.